A salvage chemotherapy of R‐P‐IMVP16/CBDCA consisting of rituximab, methylprednisolone, ifosfamide, methotrexate, etoposide, and carboplatin for patients with diffuse large B cell lymphoma who had previously received R‐CHOP therapy as first‐line chemotherapy
Takuro Matsumoto; Takeshi Hara; Yuhei Shibata; Nobuhiko Nakamura; Hiroshi Nakamura; Soranobu Ninomiya; Junichi Kitagawa; Nobuhiro Kanemura; Naoe Goto; Yusuke Kito; Senji Kasahara; Toshiki Yamada; Michio Sawada; Tatsuhiko Miyazaki; Tsuyoshi Takami; Tamotsu Takeuchi; Hisataka Moriwaki; Hisashi Tsurumi
Author Information: Department of Hematology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.